SCHEMBL5026484

SCHEMBL5026484

O=C(ONC1=NC(c2cccc(-c3ccccc3)c2)Cc2ccccc21)C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS3 P29474 6/20 0.41
NOS2 P35228 2/20 0.33
HDAC1 Q13547 2/20 0.33
HDAC2 Q92769 2/20 0.33
BACE1 P56817 2/20 0.33
NPY5R Q15761 1/20 0.32
HDAC3 O15379 1/20 0.32
HDAC4 P56524 1/20 0.32
HDAC7 Q8WUI4 1/20 0.32
HDAC10 Q969S8 1/20 0.32
HDAC11 Q96DB2 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
HDAC9 Q9UKV0 1/20 0.32
HDAC5 Q9UQL6 1/20 0.32
PDE4A P27815 1/20 0.31
PDE4B Q07343 1/20 0.31
PDE4C Q08493 1/20 0.31
PDE4D Q08499 1/20 0.31
FAAH O00519 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5025594 0.90 LMNA (0.40) NOS3BACE1HDAC6
SCHEMBL5024092 0.88 NOS3 (0.41) NOS3NOS2HDAC4MAPT
Trifluoroacetic Acid SCHEMBL5005119 0.78 NOS3 (0.61) NOS3NOS2BACE1
Trifluoroacetic Acid SCHEMBL5001533 0.72 NOS3 (0.53) NOS3NOS2BACE1HDAC6
SCHEMBL5030127 0.71 BACE1 (0.36) HDAC1HDAC2BACE1
SCHEMBL8243285 0.71 NOS3 (0.75) NOS3NOS2
Trifluoroacetic Acid SCHEMBL5001990 0.67 NOS3 (0.60) NOS3NOS2HDAC4
SCHEMBL5025791 0.66 BACE1 (0.47) BACE1HDAC6
SCHEMBL7058052 0.64 HDAC1 (0.49) HDAC1HDAC2HDAC3HDAC4HDAC7
SCHEMBL5030034 0.64 HCAR3 (0.35) HDAC9MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957462-A2 NOVEL 2-AMINO-HETEROCYCLES UDEFUL IN THE TREATMENT OF ABETA-RELATED PATHOLOGIES Astra Zeneca AB (SE) 2008-08-20 EP disclosed
WO-2007058583-A2 NOVEL 2-AMINO-HETEROCYCLES USEFUL IN THE TREATMENT OF ABETA-RELATED PATHOLOGIES ASTRAZENECA AB (SE) 2007-05-24 WO disclosed